|
US5840294A
(en)
*
|
1993-03-29 |
1998-11-24 |
Queen's University At Kingston |
Method for treating amyloidosis
|
|
US20040208875A1
(en)
*
|
1995-03-15 |
2004-10-21 |
Queen's University At Kingston |
Method for treating amyloidosis
|
|
GB9610829D0
(en)
*
|
1996-05-23 |
1996-07-31 |
Medical Res Council |
Screening of agents for treatment of azlheimers disease
|
|
EP1014996B1
(en)
*
|
1997-08-28 |
2003-05-28 |
University of Washington |
Saccharide-containing compositions for treating alzheimer's disease and other amyloidoses
|
|
WO1999040909A1
(en)
*
|
1998-02-11 |
1999-08-19 |
Neurochem, Inc. |
Method for modulating macrophage activation
|
|
US20020022657A1
(en)
*
|
1998-02-11 |
2002-02-21 |
Francine Gervais |
Methods for modulating neuronal cell death
|
|
AU2006228064C1
(en)
*
|
1998-02-11 |
2009-01-29 |
Bhi Limited Partnership |
Method for modulating macrophage activation
|
|
US6329356B1
(en)
|
1998-04-10 |
2001-12-11 |
Neurochem, Inc. |
Phosphono-carboxylate compounds for treating amyloidosis
|
|
AU2006203051C1
(en)
*
|
1998-05-15 |
2009-01-22 |
Bhi Limited Partnership |
Use of amyloid inhibitors for modulating neuronal cell death
|
|
WO1999059571A1
(en)
*
|
1998-05-15 |
1999-11-25 |
Neurochem, Inc. |
Use of amyloid inhibitors for modulating neuronal cell death
|
|
EP1609467A1
(en)
*
|
1998-07-28 |
2005-12-28 |
Neurochem (International) Limited |
Compositions for treating diseases associated with glycosaminoglycan-associated molecular interactions
|
|
US6310073B1
(en)
*
|
1998-07-28 |
2001-10-30 |
Queen's University At Kingston |
Methods and compositions to treat glycosaminoglycan-associated molecular interactions
|
|
JP4726304B2
(ja)
*
|
1999-04-28 |
2011-07-20 |
ベルス ヘルス （インターナショナル） リミティッド |
アミロイドーシスを治療するための組成物および方法
|
|
US6562836B1
(en)
*
|
1999-05-24 |
2003-05-13 |
Queen's University Of Kingston |
Methods and compounds for inhibiting amyloid deposits
|
|
AU2005203635B2
(en)
*
|
1999-05-24 |
2008-08-07 |
Bellus Health (International) Limited |
Methods and compounds for inhibiting amyloid deposits
|
|
WO2001003680A2
(en)
*
|
1999-07-09 |
2001-01-18 |
Isis Innovation Limited |
Compounds for inhibiting diseases and preparing cells for transplantation
|
|
US6310048B1
(en)
|
1999-12-09 |
2001-10-30 |
St. Louis University |
Antisense modulation of amyloid beta protein expression
|
|
AU8431301A
(en)
*
|
1999-12-23 |
2001-11-20 |
Neurochem (International) Limited |
Compounds and methods for modulating cerebral amyloid angiopathy
|
|
JP2005231998A
(ja)
*
|
2000-02-01 |
2005-09-02 |
Zeria Pharmaceut Co Ltd |
透析アミロイド線維重合核の製造方法及び透析アミロイド−シス治療剤のスクリーニング方法並びに透析アミロイドーシス治療剤
|
|
US7311893B2
(en)
*
|
2000-07-25 |
2007-12-25 |
Neurochem (International) Limited |
Amyloid targeting imaging agents and uses thereof
|
|
US20020115717A1
(en)
*
|
2000-07-25 |
2002-08-22 |
Francine Gervais |
Amyloid targeting imaging agents and uses thereof
|
|
US20070208087A1
(en)
|
2001-11-02 |
2007-09-06 |
Sanders Virginia J |
Compounds, compositions and methods for the treatment of inflammatory diseases
|
|
IL160208A0
(en)
*
|
2001-08-31 |
2004-07-25 |
Neurochem Int Ltd |
Amidine derivatives for treating amyloidosis
|
|
ES2368907T3
(es)
|
2002-04-19 |
2011-11-23 |
The Governing Council Of The University Of Toronto |
Procedimientos y composiciones inmunológicas para el tratamiento de la enfermedad de alzheimer.
|
|
SI2527315T1
(sl)
*
|
2002-05-31 |
2014-06-30 |
Proteotech Inc., |
Spojine, sestavki in metode za zdravljenje amiloidnih bolezni in sinukleinopatij, kot so Alzheimerjeva bolezen, diabetes tipa 2 in Parkinsonova bolezen
|
|
US20040057949A1
(en)
*
|
2002-09-23 |
2004-03-25 |
Depaolis Potito U. |
Hemodialysis method for improving immune system function
|
|
US20050031651A1
(en)
*
|
2002-12-24 |
2005-02-10 |
Francine Gervais |
Therapeutic formulations for the treatment of beta-amyloid related diseases
|
|
CA2511599A1
(en)
*
|
2002-12-24 |
2004-07-15 |
Neurochem (International) Limited |
Therapeutic formulations for the treatment of beta-amyloid related diseases
|
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
|
US7521481B2
(en)
|
2003-02-27 |
2009-04-21 |
Mclaurin Joanne |
Methods of preventing, treating and diagnosing disorders of protein aggregation
|
|
EP1635823A1
(en)
*
|
2003-05-20 |
2006-03-22 |
TransTech Pharma Inc. |
Rage antagonists as agents to reverse amyloidosis and diseases associated therewith
|
|
JP2007521255A
(ja)
*
|
2003-06-23 |
2007-08-02 |
ニューロケム （インターナショナル） リミテッド |
タンパク質凝集疾患を治療するための方法
|
|
US7244764B2
(en)
|
2003-06-23 |
2007-07-17 |
Neurochem (International) Limited |
Methods and compositions for treating amyloid-related diseases
|
|
US20050142191A1
(en)
|
2003-06-23 |
2005-06-30 |
Neurochem (International) Limited |
Pharmaceutical formulations of amyloid inhibiting compounds
|
|
US20070010573A1
(en)
*
|
2003-06-23 |
2007-01-11 |
Xianqi Kong |
Methods and compositions for treating amyloid-related diseases
|
|
US20060079578A1
(en)
*
|
2003-06-23 |
2006-04-13 |
Julie Laurin |
Pharmaceutical formulations of amyloid inhibiting compounds
|
|
HRP20140442T1
(hr)
*
|
2003-06-23 |
2014-07-04 |
Kiacta Sàrl |
Metoda za pripremu spoja 1,3-propan disulfonske kiseline
|
|
US7414076B2
(en)
*
|
2003-06-23 |
2008-08-19 |
Neurochem (International) Limited |
Methods and compositions for treating amyloid-related diseases
|
|
AU2011250847B2
(en)
*
|
2003-06-23 |
2013-06-20 |
Bhi Limited Partnership |
Methods and compositions for treating amyloid-related diseases
|
|
JP2007516940A
(ja)
*
|
2003-06-23 |
2007-06-28 |
ニューロケム （インターナショナル） リミテッド |
改善された薬剤候補およびその調製法
|
|
AU2004249529A1
(en)
*
|
2003-06-23 |
2004-12-29 |
Bellus Health (International) Limited |
Methods and compositions for treating amyloid-related diseases
|
|
US7253306B2
(en)
|
2003-06-23 |
2007-08-07 |
Neurochem (International) Limited |
Pharmaceutical drug candidates and methods for preparation thereof
|
|
US7262223B2
(en)
*
|
2004-01-23 |
2007-08-28 |
Neurochem (International) Limited |
Amidine derivatives for treating amyloidosis
|
|
JP4753022B2
(ja)
*
|
2004-02-17 |
2011-08-17 |
独立行政法人産業技術総合研究所 |
プリオン増殖抑制剤
|
|
US20050267029A1
(en)
*
|
2004-04-02 |
2005-12-01 |
Ancsin John B |
Compounds which modulate amyloidogenesis and methods for their identification and use
|
|
WO2006059252A2
(en)
*
|
2004-11-12 |
2006-06-08 |
Neurochem (International) Limited |
Methods and fluorinated compositions for treating amyloid-related diseases
|
|
CN101103018A
(zh)
*
|
2004-11-16 |
2008-01-09 |
神经化学（国际）有限公司 |
治疗cns和淀粉样蛋白-相关疾病的化合物
|
|
EP2186518A1
(en)
*
|
2004-11-17 |
2010-05-19 |
McLaurin, Joanne |
Composition and methods for treatment of disorders of protein aggregation
|
|
US8044100B2
(en)
*
|
2004-12-22 |
2011-10-25 |
Bellus Health Inc. |
Methods and compositions for treating amyloid-related diseases
|
|
CN101193628A
(zh)
*
|
2005-04-12 |
2008-06-04 |
神经化学（国际）有限公司 |
淀粉样蛋白抑制性化合物的药物制剂
|
|
TW200716088A
(en)
*
|
2005-04-15 |
2007-05-01 |
Neurochem Int Ltd |
Formulations and methods for treating amyloidosis
|
|
AU2006251832A1
(en)
*
|
2005-05-27 |
2006-11-30 |
Queen's University At Kingston |
Treatment of protein folding disorders
|
|
US20070049638A1
(en)
*
|
2005-07-21 |
2007-03-01 |
Neurochem (International) Limited |
Polymorphic forms of 3-amino-1-propanesulfonic acid
|
|
AU2006321294A1
(en)
*
|
2005-09-30 |
2007-06-07 |
Bellus Health (International) Limited |
Pharmaceutical compositions comprising carboxyalkylsulfonic acids
|
|
CA2626005A1
(en)
*
|
2005-10-13 |
2007-10-25 |
Waratah Pharmaceuticals Inc. |
Inositol derivatives and their uses in the treatment of diseases characterized by abnormal protein folding or aggregation or amyloid formation, deposition, accumulation or persistence
|
|
PL1976877T5
(pl)
|
2005-11-30 |
2017-09-29 |
Abbvie Inc |
Przeciwciała monoklonalne przeciwko białku amyloidu beta oraz ich zastosowania
|
|
PT1954718E
(pt)
|
2005-11-30 |
2014-12-16 |
Abbvie Inc |
Anticorpos anti-globulómeros aβ, suas porções de ligação ao antigénio, correspondentes hibridomas, ácidos nucleicos, vectores, células hospedeiras, métodos de produção dos ditos anticorpos, composições compreendendo os ditos anticorpos, usos dos ditos anticorpos e métodos para uso dos ditos anticorpos
|
|
BRPI0620637A2
(pt)
*
|
2005-12-22 |
2011-11-16 |
Neurochem Int Ltd |
uso de compostos na preparação de medicamentos para a prevenção ou o tratamento de nefropatia diabética, complicação de desordem renal e dislipidemia, redução dos nìveis de lipìdeos e ácido úrico no soro, e aumento do clearance de creatinina e da função renal
|
|
EP1976495A2
(en)
*
|
2006-01-06 |
2008-10-08 |
Aarhus Universitet |
Compounds acting on the serotonin transporter
|
|
US20070197452A1
(en)
*
|
2006-02-17 |
2007-08-23 |
Mclaurin Joanne |
Treatment of amyloid-related diseases
|
|
NZ571181A
(en)
*
|
2006-03-09 |
2011-12-22 |
Waratah Pharmaceuticals Inc |
A cyclohexane polyalcohol formulation for treatment of disorders of protein aggregation
|
|
CA2652449A1
(en)
*
|
2006-05-19 |
2007-11-29 |
Waratah Pharmaceuticals Inc. |
Screening methods for amyloid beta modulators
|
|
US20100173960A1
(en)
*
|
2006-09-21 |
2010-07-08 |
Antonio Cruz |
The Combination of a Cyclohexanehexol and a NSAID for the Treatment of Neurodegenerative Diseases
|
|
CN101600730B
(zh)
|
2006-10-12 |
2014-01-29 |
Bhi有限合资公司 |
递送3-氨基-1-丙磺酸的方法、化合物、组合物和载体
|
|
JP2010510254A
(ja)
*
|
2006-11-24 |
2010-04-02 |
ワラタ ファーマシューティカルズ， インコーポレイテッド |
アルツハイマー病および関連の神経変性疾患のための併用処置
|
|
US8455626B2
(en)
|
2006-11-30 |
2013-06-04 |
Abbott Laboratories |
Aβ conformer selective anti-aβ globulomer monoclonal antibodies
|
|
JP2010513219A
(ja)
*
|
2006-12-22 |
2010-04-30 |
ベラス ヘルス （インターナショナル） リミテッド |
腎臓の疾患、糖尿病性腎症及び脂質代謝異常の治療
|
|
CA2673022A1
(en)
*
|
2006-12-22 |
2008-07-03 |
Bellus Health (International) Limited |
Methods, compounds, and compositions for treating metabolic disorders and diabetes
|
|
US20100311767A1
(en)
|
2007-02-27 |
2010-12-09 |
Abbott Gmbh & Co. Kg |
Method for the treatment of amyloidoses
|
|
AR060411A1
(es)
*
|
2007-04-10 |
2008-06-18 |
Creactivar S A |
Una composicion farmaceutica utilizable en el tratamiento o prevencion de una enfermedad pulmonar y uso de la n-sulfoetilnicotinamida en el tratamiento o prevencion de dicha enfermedad
|
|
AR060412A1
(es)
*
|
2007-04-10 |
2008-06-18 |
Creactivar S A |
Una composicion farmaceutica utilizable para inhibir o evitar la formacion no deseada de tejido fibroso y uso de la n- sulfoetilnicotinamida para inhibir o evitar la formacion no deseada de tejido fibroso
|
|
US20100331267A1
(en)
*
|
2007-04-12 |
2010-12-30 |
Mclaurin Joanne |
Use of cyclohexanehexol derivatives in the treatment of alpha-synucleinopathies
|
|
CA2683607A1
(en)
*
|
2007-04-12 |
2008-10-23 |
Waratah Pharmaceuticals Inc. |
Use of cyclohexanehexol derivatives in the treatment of ocular diseases
|
|
WO2008124931A1
(en)
*
|
2007-04-12 |
2008-10-23 |
Joanne Mclaurin |
Use of cyclohexanehexol derivatives in the treatment of amyotrophic lateral sclerosis
|
|
US20110105626A1
(en)
*
|
2007-04-12 |
2011-05-05 |
Mclaurin Joanne |
Use of cyclohexanehexol derivatives for the treatment of polyglutamine diseases
|
|
US8613923B2
(en)
|
2007-06-12 |
2013-12-24 |
Ac Immune S.A. |
Monoclonal antibody
|
|
US8048420B2
(en)
|
2007-06-12 |
2011-11-01 |
Ac Immune S.A. |
Monoclonal antibody
|
|
PT2238166E
(pt)
|
2007-10-05 |
2014-02-11 |
Genentech Inc |
Utilização do anticorpo anti-amilóide beta em doenças oculares
|
|
US20100093648A1
(en)
*
|
2008-10-09 |
2010-04-15 |
Antonio Cruz |
Treatment of macular degeneration-related disorders
|
|
US9051248B2
(en)
*
|
2009-08-10 |
2015-06-09 |
Bhi Limited Partnership |
Methods, compounds, and compositions for delivering 1,3-propanedisulfonic acid
|
|
KR101737775B1
(ko)
*
|
2009-09-17 |
2017-05-19 |
베스포크 바이오사이언스, 엘엘씨. |
통증 조절 및 탈수초 손상의 역전에서의 ｎ―2―하이드록시―에틸―피페라진―ｎ‘―2―에탄 설폰산（ｈｅｐｅｓ）의 역할
|
|
TWI517850B
(zh)
|
2009-09-30 |
2016-01-21 |
Ｖｔｖ治療有限責任公司 |
經取代之咪唑衍生物及其使用方法
|
|
KR101173677B1
(ko)
*
|
2009-12-11 |
2012-08-13 |
한국과학기술연구원 |
Ｅｐｐｓ를 유효성분으로 함유하는 베타아밀로이드 집적 관련 질환의 예방 또는 치료용 약학적 조성물
|
|
CN102933601B
(zh)
|
2010-04-15 |
2016-06-08 |
Abbvie公司 |
β淀粉样蛋白结合蛋白
|
|
MY164579A
(en)
|
2010-07-30 |
2018-01-15 |
Ac Immune Sa |
Safe and functional humanized antibodies
|
|
MX358739B
(es)
|
2010-08-14 |
2018-09-03 |
Abbvie Inc Star |
Proteinas de union a amiloide beta.
|
|
US9717710B2
(en)
|
2012-10-05 |
2017-08-01 |
Vtv Therapeutics Llc |
Treatment of mild and moderate Alzheimer's disease
|
|
WO2018156845A1
(en)
*
|
2017-02-24 |
2018-08-30 |
Alzheon, Inc. |
Methods for treating neurodegenerative disorders
|
|
CN108623501B
(zh)
|
2017-03-21 |
2022-04-19 |
润佳（苏州）医药科技有限公司 |
同位素富集的3-氨基-1-丙磺酸衍生物及其用途
|
|
CN109394746A
(zh)
*
|
2017-08-15 |
2019-03-01 |
江西青峰药业有限公司 |
乙基硫酸铵在制备用于预防或治疗炎症性疾病药物中的应用
|
|
WO2019190823A1
(en)
|
2018-03-28 |
2019-10-03 |
Vtv Therapeutics Llc |
Pharmaceutically acceptable salts of [3-(4- {2-butyl-1-[4-(4-chlorophenoxy)-phenyl]-1h-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amine
|
|
WO2019190822A1
(en)
|
2018-03-28 |
2019-10-03 |
Vtv Therapeutics Llc |
Crystalline forms of [3-(4- {2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1h-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amine
|
|
SG11202100767XA
(en)
*
|
2018-08-01 |
2021-02-25 |
Alzheon Inc |
Methods for treating neurodegenerative disorders
|
|
EA202190359A1
(ru)
*
|
2018-08-01 |
2021-09-27 |
Алжеон, Инк. |
Способы лечения нейродегенеративных расстройств
|
|
EP3864008A1
(en)
|
2018-10-10 |
2021-08-18 |
vTv Therapeutics LLC |
Metabolites of [3-(4-{2-butyl-l-[4-(4-chloro-phenoxy)-phenyl]-lh-imidazol-4-yl } -phen ox y)-prop yl] -diethyl-amine
|
|
CN112791078B
(zh)
|
2019-11-13 |
2022-12-06 |
润佳（苏州）医药科技有限公司 |
同位素富集的3-氨基-1-丙磺酸及其衍生物的用途
|